☰

Joshua C. Curtin, Ph.D. - Publications

Affiliations: 
2004 Dartmouth College, Hanover, NH, United States 
Area:
Pharmacology, Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

5 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2007 Schupp M, Curtin JC, Kim RJ, Billin AN, Lazar MA. A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity. Molecular Pharmacology. 71: 1251-7. PMID 17290005 DOI: 10.1124/Mol.106.033662  0.332
2005 Curtin JC, Spinella MJ. p53 in human embryonal carcinoma: identification of a transferable, transcriptional repression domain in the N-terminal region of p53. Oncogene. 24: 1481-90. PMID 15674351 DOI: 10.1038/Sj.Onc.1208130  0.553
2003 Harmes DC, Bresnick E, Lubin EA, Watson JK, Heim KE, Curtin JC, Suskind AM, Lamb J, DiRenzo J. Positive and negative regulation of ΔN-p63 promoter activity by p53 and ΔN-p63-α contributes to differential regulation of p53 target genes Oncogene. 22: 7607-7616. PMID 14576823 DOI: 10.1038/Sj.Onc.1207129  0.505
2003 Spinella MJ, Kerley JS, White KA, Curtin JC. Retinoid target gene activation during induced tumor cell differentiation: human embryonal carcinoma as a model. The Journal of Nutrition. 133: 273S-276S. PMID 12514308 DOI: 10.1093/Jn/133.1.273S  0.489
2001 Curtin JC, Dragnev KH, Sekula D, Christie AJ, Dmitrovsky E, Spinella MJ. Retinoic acid activates p53 in human embryonal carcinoma through retinoid receptor-dependent stimulation of p53 transactivation function. Oncogene. 20: 2559-69. PMID 11420666 DOI: 10.1038/Sj.Onc.1204370  0.555
Show low-probability matches.